GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:14967141
| Citation |
Yu, C, Minemoto, Y, Zhang, J, Liu, J, Tang, F, Bui, TN, Xiang, J and Lin, A (2004) JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol. Cell 13:329-40 |
|---|---|
| Abstract |
JNK has been suggested to be proapoptotic, antiapoptotic, or have no role in apoptosis depending on the cell type and stimulus used. The precise mechanism of JNK action, under conditions when it promotes cell survival, is not entirely clear. Here, we report that JNK is required for IL-3-mediated cell survival through phosphorylation and inactivation of the proapoptotic Bcl-2 family protein BAD. IL-3 withdrawal-induced apoptosis is promoted by inhibition of JNK but suppressed by expression of a constitutively active JNK. JNK phosphorylates BAD at threonine 201, thereby inhibiting BAD association with the antiapoptotic molecule BCL-X(L). IL-3 induces BAD phosphorylation at threonine 201, and replacement of threonine 201 by alanine generates a BAD mutant, which promotes IL-3 withdrawal-induced apoptosis. Thus, our results provide a molecular mechanism by which JNK contributes to cell survival. |
| Links | |
| Keywords |
Alanine/metabolism; Animals; Apoptosis/drug effects; Apoptosis/physiology; Carrier Proteins/genetics; Carrier Proteins/metabolism; Cell Line; Cell Survival/drug effects; Cell Survival/physiology; Interleukin-3/metabolism; Interleukin-3/pharmacology; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinases/metabolism; Mutation/genetics; Phosphorylation; Proto-Oncogene Proteins c-bcl-2/metabolism; Threonine/metabolism; bcl-Associated Death Protein; bcl-X Protein |
| edit table |
Significance
Annotations
| Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| edit table |
See also
References
See Help:References for how to manage references in GONUTS.
